HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility
BackgroundA deep understanding of the causes of liability to SARS-CoV-2 is essential to develop new diagnostic tests and therapeutics against this serious virus in order to overcome this pandemic completely. In the light of the discovered role of antimicrobial peptides [such as human b-defensin-2 (h...
Autors principals: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Frontiers Media S.A.
2022-12-01
|
Col·lecció: | Frontiers in Immunology |
Matèries: | |
Accés en línia: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008463/full |